IACOVIELLO, Massimo
 Distribuzione geografica
Continente #
EU - Europa 4.740
NA - Nord America 3.922
AS - Asia 3.167
SA - Sud America 997
AF - Africa 94
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.931
Nazione #
US - Stati Uniti d'America 3.805
IE - Irlanda 1.961
SG - Singapore 1.427
BR - Brasile 834
SE - Svezia 731
RU - Federazione Russa 574
HK - Hong Kong 552
CN - Cina 441
VN - Vietnam 415
UA - Ucraina 304
IT - Italia 289
FI - Finlandia 250
DE - Germania 247
GB - Regno Unito 109
IN - India 79
AR - Argentina 69
CA - Canada 55
CZ - Repubblica Ceca 54
BD - Bangladesh 42
ID - Indonesia 40
FR - Francia 38
MX - Messico 35
AT - Austria 33
BE - Belgio 31
IQ - Iraq 31
PL - Polonia 28
TR - Turchia 28
ZA - Sudafrica 27
EC - Ecuador 24
NL - Olanda 22
PY - Paraguay 19
CL - Cile 17
ES - Italia 15
MA - Marocco 15
PK - Pakistan 14
CO - Colombia 13
JP - Giappone 12
KE - Kenya 11
UZ - Uzbekistan 11
RO - Romania 10
PE - Perù 9
DZ - Algeria 8
JM - Giamaica 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
NP - Nepal 7
NZ - Nuova Zelanda 7
VE - Venezuela 7
AZ - Azerbaigian 6
BG - Bulgaria 6
EG - Egitto 6
JO - Giordania 6
SA - Arabia Saudita 6
TN - Tunisia 6
PT - Portogallo 5
RS - Serbia 5
AL - Albania 4
HN - Honduras 4
IR - Iran 4
MD - Moldavia 4
MU - Mauritius 4
AU - Australia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MK - Macedonia 2
NI - Nicaragua 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
Totale 12.914
Città #
Dublin 1.960
Dallas 721
Singapore 612
Hong Kong 543
Nyköping 492
Ashburn 491
Chandler 341
Jacksonville 271
Santa Clara 255
Helsinki 224
The Dalles 200
Princeton 175
Moscow 132
Beijing 125
Ho Chi Minh City 122
Munich 105
Wilmington 98
Dong Ket 96
São Paulo 75
Hanoi 71
Los Angeles 68
New York 61
Brno 47
Nuremberg 32
London 30
Shanghai 30
Washington 30
Brooklyn 29
Rio de Janeiro 29
Des Moines 28
Brussels 27
Warsaw 27
Milan 26
Falkenstein 25
Bari 22
Guangzhou 22
Turku 21
Assago 20
Brasília 20
Seattle 20
Da Nang 19
Stevenage 19
Belo Horizonte 18
Vienna 18
Pune 17
San Francisco 17
Toronto 17
Porto Alegre 16
Boardman 15
Frankfurt am Main 15
Hanover 14
Norwalk 14
Boston 13
Düsseldorf 13
Haiphong 13
Nanjing 13
Rome 13
Baghdad 12
Chicago 12
Jakarta 12
Johannesburg 12
Mexico City 11
Nairobi 11
Tashkent 11
Tokyo 11
Dhaka 10
Ottawa 10
Guayaquil 9
Jiaxing 9
Ninh Bình 9
Phoenix 9
Stockholm 9
Wuhan 9
Buenos Aires 8
Campinas 8
Chennai 8
Curitiba 8
Quito 8
Ribeirão Preto 8
Sorocaba 8
Uberlândia 8
Can Tho 7
Caxias do Sul 7
Council Bluffs 7
Fortaleza 7
Goiânia 7
Guarulhos 7
Kingston 7
Lund 7
Mauá 7
Miami 7
Montreal 7
New Delhi 7
Providence 7
Redwood City 7
Amman 6
Asunción 6
Atlanta 6
Casablanca 6
Hortolândia 6
Totale 8.345
Nome #
12-lead electrocardiogram features of arrhythmic risk: A focus on early repolarization 545
2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases: what's new? The cardiologist's point of view 131
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 123
Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role 113
Association between high Gal-3 serum levels and worsening of renal function in chronic heart failure outpatients 106
Heart failure in frail elderly resident in a nurse house: Prognostic significance of a multimarker approach 103
Position paper ANMCO sull'utilizzo della terapia con sacubitril/valsartan nel paziente con scompenso cardiaco 100
The 212A variant of the APJ receptor gene for the endogenous inotrope apelin is associated with slower heart failure progression in idiopathic dilated cardiomyopathy 93
Biomarkers in cardiorenal syndrome 92
Reverse remodelling induced by resynchronization therapy is associated to renin-angiotensin system activity improvement 91
ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: The clinical-diagnostic and therapeutic pathway of patients with acute heart failure in the Emergency Department 91
Influence of Heart Rate on Left and Right Ventricular Longitudinal Strain in Patients with Chronic Heart Failure 90
Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure 88
Renal resistance index independently predicts worsening of renal function after coronary angiography 87
Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure 86
Right Ventricular Function in Chronic Heart Failure: From the Diagnosis to the Therapeutic Approach 85
ANMCO Position paper: Use of sacubitril/valsartan in hospitalized patients with acute heart failure 85
[ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU consensus document: The clinical care pathway of acute heart failure patients from symptom onset to discharge from the emergency department] 84
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure 84
Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony 83
The effects of heart rate control in chronic heart failure with reduced ejection fraction 83
Multicenter APULIA HF study: Efficacy of a shared management protocol between hospital and territory of patients hospitalized for acute heart failure 83
Meta-Regression Analysis of the Impact of Medical Therapy on Long-Term Mortality in Type 2 Myocardial Infarction 83
Accuracy of bioimpedance vector analysis and brain natriuretic peptide in detection of peripheral edema in acute and chronic heart failure 81
Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan 81
Dysthyroidism and chronic heart failure: pathophysiological mechanisms and therapeutic approaches 80
ANMCO Position paper. From acute to chronic disease: The needs of complex cardiac patients 80
Metformin: Up to date 80
Cardiac contractility modulation in left ventricular systolic dysfunction: trick or treat? 80
Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction 79
[Vitamin D deficiency and cardiovascular diseases] 79
Comparative study of galectin-3, brain natriuretic peptide, cystantine C and high sensitivity troponin determinations in the diagnosis of heart failure in elderly Italian males 78
Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study 78
The renal arterial resistance index predicts worsening renal function in chronic heart failure patients 78
Multivessel spontaneous coronary artery dissection and Crohn's disease 78
Sensibilità cardiopolmonare e chemosensibilità 77
Short term reverse remodeling predicts long term haemodynamic improvement after cardiac resynchronization therapy 76
Amiodarone-induced SIADH: two cases report 76
Shortened head-up tilting test guided by systolic pressure reductions in neurocardiogenic syncope 76
Arrhythmic myocarditis in an adolescent male: A unique presentation of multi-organ inflammatory syndrome (MIS-C) 75
Respiratory failure and bioelectrical phase angle are independent predictors for long-term survival in acute heart failure 75
Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype 75
Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring 75
Galectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients 75
ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device 74
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 74
Right ventriculo-arterial coupling assessed by two-dimensional strain: A new parameter of right ventricular function independently associated with prognosis in chronic heart failure patients 74
Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? 74
Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia/cardiomyopathy 74
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 73
Thyroid disorders and prognosis in chronic heart failure: A long-term follow-up study 73
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic 73
Critical appraisal of multivariable prognostic scores in heart failure: Development, validation and clinical utility 72
Prognostic role of neoplastic markers in Takotsubo syndrome 72
Influence of hydrophilic and lipophilic beta-blockers on heart rate, ventricular repolarization and their interrelationship in normal subjects 71
Low thyroid function is not associated with an accelerated deterioration in renal function 71
Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use? 71
ANMCO Position paper: Double, triple or quadruple therapy for heart failure with reduced ejection fraction. Current evidence and new strategies 71
Clinical predictors of head-up tilt test outcome during the nitroglycerin phase 70
Head-up tilt testing for diagnosing vasovagal syncope: A meta-analysis 70
Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction 69
ANMCO Position paper: Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in diabetic patients and for the treatment of heart failure patients with and without diabetes 69
Recent Non-Invasive Parameters to Identify Subjects at High Risk of Sudden Cardiac Death 68
Right ventriculo-arterial coupling in heart failure: The role of the interventricular septum 68
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? 68
Cardiac resynchronization therapy improves autonomic control of heart rate 67
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure 67
Predictors of clinical improvement with sacubitril/valsartan in a real world population with chronic heart failure 67
Revascularization rates with coronary angioplasty and mortality in type 2 myocardial infarction: A meta-regression analysis 67
Dolichocarotids and dilated cardiomyopathy: is there a relationship? 66
The independent association between altered renal arterial resistance and loop diuretic dose in chronic heart failure outpatients 66
ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure 66
The renal arterial resistance index: a marker of renal function with an independent and incremental role in predicting heart failure progression 66
Targeted next-generation sequencing detects novel gene–phenotype associations and expands the mutational spectrum in cardiomyopathies 66
Measures of hospital competition and their impact on early mortality for congestive heart failure, acute myocardial infarction and cardiac surgery 66
Continuous flow left ventricular assist devices do not worsen endothelial function in subjects with chronic heart failure: a pilot study 66
A Multiparametric Approach Based on NT-proBNP, ST2, and Galectin3 for Stratifying One Year Prognosis of Chronic Heart Failure Outpatients 66
Near zero vascular complications using echo-guided puncture during catheter ablation of arrhythmias: A retrospective study and literature review 65
Influence of gender and family history of hypertension on autonomic control of heart rate, diastolic function and brain natriuretic peptide 65
ANMCO/SIC Consensus Document: cardiology networks for outpatient heart failure care 65
Effects of Sacubitril/Valsartan on the Renal Resistance Index 64
Reverse cardiac remodeling after fluid balance optimization in patients with end-stage renal disease 64
BNP in mitral valve restrictive annuloplasty for ischemic mitral regurgitation 64
Optimizing Therapies in Heart Failure: The Role of Potassium Binders 62
Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances 62
Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone 62
Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy 62
Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction 61
GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis 60
A novel cardiac bio-marker: ST2: a review 60
Endocrine system dysfunction and chronic heart failure: a clinical perspective 60
Echocardiographic but not electrocardiographic measures of left ventricular asynchrony predicts short- and long-term functional improvement after cardiac resynchronization therapy. 59
Independent role of left ventricular global longitudinal strain in predicting prognosis of chronic heart failure patients 59
Early mortality following percutaneous coronary intervention and cardiac surgery: Correlations within providers and operators 59
Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy 59
Role of imaging in the evaluation of renal dysfunction in heart failure patients 59
Exploring the Impact of Artificial Intelligence on Healthcare Management: A Combined Systematic Review and Machine-Learning Approach 58
Serum biochemical determinants of peripheral congestion assessed by bioimpedance vector analysis in acute heart failure 58
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches 58
Mineralcorticoid Receptor Antagonist Withdrawal for Hyperkalemia and Mortality in Patients with Heart Failure 57
Totale 7.938
Categoria #
all - tutte 104.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021843 0 0 0 0 0 5 144 277 173 136 0 108
2021/2022868 28 2 3 13 101 34 66 81 108 149 33 250
2022/20233.634 350 134 155 68 105 375 6 217 2.059 26 70 69
2023/2024700 82 28 48 20 85 192 10 59 3 22 31 120
2024/20253.661 254 28 54 74 89 500 510 190 1.087 165 417 293
2025/20263.644 359 631 1.207 1.011 320 116 0 0 0 0 0 0
Totale 13.717